Related references
Note: Only part of the references are listed.Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men
Robert Clarke et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence
G Walldius et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
PJ Barter et al.
JOURNAL OF INTERNAL MEDICINE (2006)
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
D Wood et al.
HEART (2005)
Trends in serum lipids and lipoproteins of adults, 1960-2002
MD Carroll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Associations of low density lipoprotein particle composition with atherogenicity
AT Lada et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Improved estimates of floating absolute risk
M Plummer
STATISTICS IN MEDICINE (2004)
Clinical review 163 - Cardiovascular endocrinology 4 - Low-density lipoprotein size and cardiovascular disease: A reappraisal
FM Sacks et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies
S Clark et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors
PJ Barter
ATHEROSCLEROSIS SUPPLEMENTS (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
MA Austin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
Share Paper
